2021
DOI: 10.1016/j.ijbiomac.2021.08.054
|View full text |Cite
|
Sign up to set email alerts
|

Brilliant glycans and glycosylation: Seq and ye shall find

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
23
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 42 publications
(25 citation statements)
references
References 143 publications
2
23
0
Order By: Relevance
“…Studies have shown that people with schizophrenia and other psychiatric and neurological disorders have gamma oscillations in their brains ( Gao et al, 2021a , b ). But exactly how gamma oscillations are produced is not clear ( Fan et al, 2020 ; Lu W. et al, 2020 ; Song et al, 2020 ).…”
Section: Optogenetic Research Methodsmentioning
confidence: 99%
“…Studies have shown that people with schizophrenia and other psychiatric and neurological disorders have gamma oscillations in their brains ( Gao et al, 2021a , b ). But exactly how gamma oscillations are produced is not clear ( Fan et al, 2020 ; Lu W. et al, 2020 ; Song et al, 2020 ).…”
Section: Optogenetic Research Methodsmentioning
confidence: 99%
“…Despite undertaking enormous efforts, clinicians and drug makers are due to establish treatment options with long-lasting curative effects to patients suffering from advanced pancreatic cancer [ 35 , 36 ]. Advances in technologies in molecular and cell biology have enabled the scientific stakeholders to come up with novel targets that may overcome this long-lasting dilemma.…”
Section: Discussionmentioning
confidence: 99%
“…In the present study, our evidence suggested that AGTR1 attenuated cellular senescence of HCC cells through activating ERK signaling, indicating AGTR1 as a drug target against HCC. HCC is still difficult to treat due to a lack of drugs targeting key dependencies ( Gao et al, 2021 ), and broad-spectrum kinase antagonists (especially sorafenib) have little benefit in HCC patients ( Kelley et al, 2021 ; Ren et al, 2021 ; Wen et al, 2021 ). Experimental evidence suggests that sorafenib enables to facilitate cellular apoptosis and senescence and mitigates angiogenesis as well as suppresses proliferation in cancer cells ( Ding et al, 2021 ; Ryoo et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%